NEW YORK (GenomeWeb News) – Combimatrix said today that Blue Cross and Blue Shield of Kansas City (Blue KC) will cover its diagnostic lab services under a new contract agreement.

The agreement means Combimatrix's suite of testing services and clinical support solutions will be available to Blue KC's more than 800,000 members, Irvine, Calif.-based Combimatrix said. CombiMatrix's diagnostic lab specializes in prenatal, miscarriage, and pediatric testing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.